Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Lidocaine to Reduce Postoperative Opioid Consumption and Improve Recovery After Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis

NCT03893318 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03893318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03893318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Lidocaine to Reduce Postoperative Opioid Consumption and Improve Recovery After Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Terminated
Start date
July 30, 2019
Completion date
December 31, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lidocaine improves pain control after surgery by attenuating the systemic inflammatory response to surgery